Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $40.9000 (-2.15%) ($40.8000 - $42.5000) on Wed. Jul. 20, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6% (three month average) | RSI | 49 | Latest Price | $40.9000(-2.15%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.2% a day on average for past five trading days. | Weekly Trend | CAPR advances 1.4% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(8%) SKYY(8%) ARKK(7%) EWI(7%) IVE(7%) | Factors Impacting CAPR price | CAPR will decline at least -3% in a week (0% probabilities). VIXM(-5%) TLT(-5%) GLD(-4%) GDX(-4%) VCSH(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3% (StdDev 6%) | Hourly BBV | 0 () | Intraday Trend | -3.8% | | | |
|
Resistance Level | $41.45 | 5 Day Moving Average | $42.05(-2.73%) | 10 Day Moving Average | $41.43(-1.28%) | 20 Day Moving Average | $41.45(-1.33%) | To recent high | -13.9% | To recent low | 31.5% | Market Cap | $806m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |